Showing results (41-50 of 148) with videos related to
Sort By:
Pageof 15
Molecular Cell|January 20, 2009
betaTrCP- and Rsk1/2-mediated degradation of BimEL inhibits apoptosisElinor Dehan, Florian Bassermann, Daniele Guardavaccaro, et al.ACS Chemical Biology|November 16, 2012
Stabilizing the pro-apoptotic BimBH3 helix (BimSAHB) does not necessarily enhance affinity or biological activityToru Okamoto, Kerry Zobel, Anna Fedorova, et al.Blood Advances|December 20, 2019
Multiple myeloma with 1q21 amplification is highly sensitive to MCL-1 targetingAnne Slomp, Laura M Moesbergen, Jia-Nan Gong, et al.Proceedings of the National Academy of Sciences of the United States of America|December 24, 2013
Enhanced stability of Mcl1, a prosurvival Bcl2 relative, blunts stress-induced apoptosis, causes male sterility, and promotes tumorigenesisToru Okamoto, Leigh Coultas, Donald Metcalf, et al.The Journal of Biological Chemistry|September 15, 2009
Novel Bcl-2 homology-3 domain-like sequences identified from screening randomized peptide libraries for inhibitors of the pro-survival Bcl-2 proteinsErinna F Lee, Anna Fedorova, Kerry Zobel, et al.Plos One|January 18, 2013
Variability of inducible expression across the hematopoietic system of tetracycline transactivator transgenic miceMegumi Takiguchi, Lukas E Dow, Julia E Prier, et al.Nature Communications|May 25, 2016
Identification of an activation site in Bak and mitochondrial Bax triggered by antibodiesSweta Iyer, Khatira Anwari, Amber E Alsop, et al.Proceedings of the National Academy of Sciences of the United States of America|June 11, 2010
BH3 mimetics antagonizing restricted prosurvival Bcl-2 proteins represent another class of selective immune modulatory drugsEmma M Carrington, Ingela B Vikstrom, Amanda Light, et al.Oncotarget|October 31, 2015
The BIM deletion polymorphism: A paradigm of a permissive interaction between germline and acquired TKI resistance factors in chronic myeloid leukemiaTun Kiat Ko, Hui San Chin, Charles T H Chuah, et al.Journal of the American Chemical Society|January 4, 2007
(alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactionsJack D Sadowsky, W Douglas Fairlie, Erik B Hadley, et al.Pageof 15